Standard BioTools Inc.LABNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-5.2%
5Y CAGR-2.7%
Year-over-Year Change
Research and development spending
3Y CAGR
-5.2%/yr
vs +5.6%/yr prior
5Y CAGR
-2.7%/yr
Consistent
Acceleration
-10.8pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $31.88M | -48.9% |
| 2024 | $62.41M | +140.5% |
| 2023 | $25.95M | -30.6% |
| 2022 | $37.38M | -1.5% |
| 2021 | $37.94M | +4.1% |
| 2020 | $36.46M | +15.2% |
| 2019 | $31.64M | +5.4% |
| 2018 | $30.03M | -2.6% |
| 2017 | $30.83M | -19.8% |
| 2016 | $38.41M | - |